Atypical antipsychotics—recent findings and new perspectives

This publication has 104 references indexed in Scilit:

• Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol
  Life Sciences, 1987
• Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain
  Life Sciences, 1986
• Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients
  Life Sciences, 1985
• Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia
  Life Sciences, 1983
• Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
• 3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regions
  Life Sciences, 1978
• The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro
  Life Sciences, 1978
• Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process
  Life Sciences, 1978
• Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol of clozapine
  Life Sciences, 1977
• Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine
  Life Sciences, 1976